Several years ago a new lung cancer drug was being evaluated, and when the authors looked  at whose tumors shrank, they found that 82 percent were women.
Fa uns quants anys, un nou medicament  contra el càncer de pulmó s'estava avaluant, i quan els autors van analitzar  quins tumors es reduïen, van veure que en un 82 per cent  eren tumors de dones.